SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 39 di 39
Titolo Data di pubblicazione Autore(i) File
Adenosine and inflammation: Here, there and everywhere 2021 Pasquini, S.; Contri, C.; Borea, P. A.; Vincenzi, F.; Varani, K.
A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma 2021 Vincenzi, F.; Rotondo, J. C.; Pasquini, S.; Di Virgilio, F.; Varani, K.; Tognon, M.
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease 2021 Gessi, Stefania; Poloni, Tino Emanuele; Negro, Giulia; Varani, Katia; Pasquini, Silvia; Vincenzi,... Fabrizio; Borea, Pier Andrea; Merighi, Stefania
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment? 2021 Merighi, Stefania; Poloni, Tino Emanuele; Pelloni, Lucia; Pasquini, Silvia; Varani, Katia; Vincen...zi, Fabrizio; Borea, Pier Andrea; Gessi, Stefania
Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer's Disease 2022 Merighi, Stefania; Borea, Pier Andrea; Varani, Katia; Vincenzi, Fabrizio; Travagli, Alessia; Nigr...o, Manuela; Pasquini, Silvia; Suresh, R Rama; Kim, Sung Won; Volkow, Nora D; Jacobson, Kenneth A; Gessi, Stefania
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications 2022 Pasquini, Silvia; Contri, Chiara; Cappello, Martina; Borea, Pier Andrea; Varani, Katia; Vincenzi,... Fabrizio
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets 2022 Pasquini, S.; Contri, C.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K.; Vincenzi, F.
4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives 2022 Catarzi, D.; Varano, F.; Vigiani, E.; Calenda, S.; Melani, F.; Varani, K.; Vincenzi, F.; Pasquini..., S.; Mennini, N.; Nerli, G.; Dal Ben, D.; Volpini, R.; Colotta, V.
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition 2022 Papa, A.; Pasquini, S.; Contri, C.; Gemma, S.; Campiani, G.; Butini, S.; Varani, K.; Vincenzi, F.
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? 2022 Merighi, Stefania; Nigro, Manuela; Travagli, Alessia; Pasquini, Silvia; Borea, Pier Andrea; Varan...i, Katia; Vincenzi, Fabrizio; Gessi, Stefania
Synthesis of Unsymmetrical Squaramides as Allosteric GSK-3β Inhibitors Promoting β-Catenin-Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells 2022 Carullo, G.; Bottoni, L.; Pasquini, S.; Papa, A.; Contri, C.; Brogi, S.; Calderone, V.; Orlandini..., M.; Gemma, S.; Varani, K.; Butini, S.; Galvagni, F.; Vincenzi, F.; Campiani, G.
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 2023 Papa, Alessandro; Pasquini, Silvia; Galvani, Francesca; Cammarota, Mariarosaria; Contri, Chiara; ...Carullo, Gabriele; Gemma, Sandra; Ramunno, Anna; Lamponi, Stefania; Gorelli, Beatrice; Saponara, Simona; Varani, Katia; Mor, Marco; Campiani, Giuseppe; Boscia, Francesca; Vincenzi, Fabrizio; Lodola, Alessio; Butini, Stefania file con accesso da definire
Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy 2023 Fernandez, M; Nigro, M; Travagli, A; Pasquini, S; Vincenzi, F; Varani, K; Borea, Pa; Merighi, S; ...Gessi, S file con accesso da definire
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents 2023 Papa, Alessandro; Cursaro, Ilaria; Pozzetti, Luca; Contri, Chiara; Cappello, Martina; Pasquini, S...ilvia; Carullo, Gabriele; Ramunno, Anna; Gemma, Sandra; Varani, Katia; Butini, Stefania; Campiani, Giuseppe; Vincenzi, Fabrizio file con accesso da definire
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors 2023 Gianferrara, Teresa; Pavan, Matteo; Bassani, Davide; Vincenzi, Fabrizio; Pasquini, Silvia; Bolcat...o, Giovanni; Varani, Katia; Spalluto, Giampiero; Federico, Stephanie; Moro, Stefano file con accesso da definire
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? 2023 Merighi, Stefania; Travagli, Alessia; Nigro, Manuela; Pasquini, Silvia; Cappello, Martina; Contri..., Chiara; Varani, Katia; Vincenzi, Fabrizio; Borea, Pier Andrea; Gessi, Stefania file con accesso da definire
2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A1 Adenosine Receptor Positive Allosteric Modulators 2023 Oliva, Paola; Suresh, R Rama; Pasquini, Silvia; Salmaso, Veronica; Will, Edward J; Tosh, Dilip K;... Gao, Zhan-Guo; Liu, Naili; Gavrilova, Oksana; Vincenzi, Fabrizio; Varani, Katia; Jacobson, Kenneth A file con accesso da definire
Pharmacology of Adenosine Receptors: Recent Advancements 2023 Vincenzi, Fabrizio; Pasquini, Silvia; Contri, Chiara; Cappello, Martina; Nigro, Manuela; Travagli..., Alessia; Merighi, Stefania; Gessi, Stefania; Borea, Pier Andrea; Varani, Katia file con accesso da definire
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence 2024 Bedini, Annalida; Elisi, Gian Marco; Fanini, Fabiola; Retini, Michele; Scalvini, Laura; Pasquini,... Silvia; Contri, Chiara; Varani, Katia; Spadoni, Gilberto; Mor, Marco; Vincenzi, Fabrizio; Rivara, Silvia file con accesso da definire
Mostrati risultati da 21 a 39 di 39
Legenda icone

  •  file ad accesso aperto
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile